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Enteropathogenic Escherichia coli
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Abstract
The term enteropathogenic Escherichia coli (EPEC) was first used in 1955 to 
describe a number of serogroup-defined E. coli strains associated with infantile 
diarrhea. EPEC are now defined as those that produce a characteristic intestinal 
histopathology known as attaching and effacing (A/E) and do not produce Shiga 
toxins. EPEC carry the locus for enterocyte effacement (LEE) pathogenicity island, 
which contains the eae gene that encodes an outer membrane protein called intimin. 
Typical EPEC (tEPEC) carry a virulence plasmid known as the pEAF (EPEC adhe-
sion factor plasmid) which encodes the bundle-forming pilus (BFP) that mediate 
localized adherence to epithelial cells, whereas atypical EPEC (aEPEC) do not pos-
sess this plasmid. Typical EPEC strains have been associated with severe outbreaks 
of infant diarrhea in developing countries. Atypical EPEC strains have been linked 
to diarrhea outbreaks at all ages worldwide. Diarrhea due to aEPEC in children is 
not as severe as that caused by tEPEC.
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1. History and definition of EPEC
Escherichia coli were first recognized as diarrheal pathogens in 1898, when Lesage 
demonstrated that serum from diarrhea patients agglutinated strains of E. coli iso-
lated from other patients in the same outbreak but not those of control [1]. In 1945, 
Bray discovered that E. coli strains of certain serogroups were the predominant 
cause of summer diarrhea in infants in the United Kingdom [2]. In 1947, Kauffman 
published a serotyping scheme based on somatic (O), flagellar (H), and capsular 
(K) antigens, providing a reliable method of typing diarrheagenic E. coli [3].
The term enteropathogenic Escherichia coli (EPEC) was introduced in 1955 to 
describe strains of E. coli implicated epidemiologically with infant diarrhea in the 
1940s and 1950s [4]. This definition changed as additional serotypes were associ-
ated with infantile diarrhea. EPEC were recognized as important causes of infant 
diarrhea in the 1950s and 1960s in the developed world and subsequently have been 
shown to be common agents of gastroenteritis in the developing world. The con-
firmation that EPEC strains were pathogenic came from human volunteer studies 
carried out by Levine et al. [5].
The definition of EPEC has changed as various mechanisms of pathogenesis have 
been discovered. During the late 1960s and early 1970s, two other diarrheagenic E. 
coli strains were discovered, strains producing the heat-stable enterotoxin (ST) and 
the heat-labile enterotoxin (LT) were designated enterotoxigenic E. coli (ETEC), 
and strains demonstrating Shigella-like invasiveness were designated enteroinva-
sive E. coli (EIEC). At this time, the original definition of EPEC by Neter [4] has 
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undergone modification considerably. EPEC were then defined as “diarrheagenic E. 
coli belonging to serogroups epidemiologically incriminated as pathogens but whose 
pathogenic mechanisms have not been proven to be related either heat-labile (LT) or 
heat-stable enterotoxins (ST) or to Shigella-like invasiveness” [6].
In 1979, the first phenotype characteristic other than serotyping associated 
with EPEC was the observation of Cravioto et al. [7] that 80% of EPEC strains as 
defined by serotype could adhere to HEp-2 cells in cell culture, while most non-
EPEC strains could not. Later, the adherence pattern of EPEC was described as 
“localized adherence” (LA), based on the presence of clusters or microcolonies on 
the surface of HEp-2 cells [8]. Baldini et al. [9] subsequently showed that the ability 
of EPEC E2348/69 strain (O127:H6) to adhere in a localized adherence pattern was 
associated with the presence of a 60-MDa plasmid. EPEC strains representing a 
variety of serotypes were found to possess highly conserved high molecular weight 
plasmids associated with localized adherence, the so-called EPEC adherence factor 
(EAF) plasmids [10, 11]. Subsequently, differences in adherence patterns were 
discerned by Scaletsky et al. [8] and Nataro et al. [12], giving rise to two other 
categories of diarrheagenic E. coli and diffusely adherent E. coli and enteroaggrega-
tive E. coli. Also in the 1980s, a newly recognized clinical syndrome caused by E. 
coli led to the discovery that some diarrheagenic E. coli produce a potent cytotoxin 
known as Shiga toxin (Stx).
In 1983, Moon et al. [13] published electron micrographs of pigs and rabbits 
infected with EPEC and coined the term “attaching and effacing” (A/E) to describe 
the loss of microvilli, intimate attachment of the bacteria to the host, and formation 
of pedestals at the sits of bacteria attachment. In 1987, a number of studies clarified 
the relationship between LA phenotype and A/E lesion, which confirmed earlier 
reports that LA is associated with the EAF plasmid, and demonstrated for the first 
time that A/E is encoded on the chromosome [14].
Originally defined by serotype, EPEC are now defined as those having the 
ability to cause diarrhea, the ability to produce A/E histopathology on the intestinal 
epithelium, and the inability to produce Shiga toxins based on pathogenic charac-
teristics [15]. Improvements in techniques allowing a better understanding of the 
genome and virulence mechanisms among EPEC strains over the years have led to 
the classification into “typical” and “atypical” subtypes based on the presence or 
absence of the pEAF plasmid [15].
2. Atypical versus typical EPEC
Most of the typical EPEC strains belong to the traditional EPEC serogroups O55, 
O86, O111, O114, O119, O127, and O142, and the most common flagellar antigens 
are H6 and H2 [16, 17]. A less common EPEC type is H34, and a number of typical 
EPEC strains are nonmotile in conventional testes and classified as H-. Typical 
EPEC strains belonging to nonclassic serotypes have also been reported [18, 19]. 
Currently, more than 180 different O serogroups and more than 60 H antigens are 
recognized. Atypical EPEC belong to a large diversity of classical and nonclassical 
serotypes [18, 20]. Based on multilocus enzyme electrophoresis analysis of allelic 
differences among housekeeping genes, typical EPEC strains have been subtyped 
into two major lineages, previously designated EPEC1 and EPEC2 [16, 17]. EPEC1 
includes serotypes O55:H6 and O119:H6, whereas EPEC2 consists of serotypes 
O111:H2 and O114:H2. Recently, EPEC strains have been demonstrated to cluster in 
three main lineages, designated EPEC1, EPEC2, and EPEC4, which probably acquired 
the locus of enterocyte effacement region (LEE) and pEAF independently [21].  
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Interestingly, it has been found that 35% of the atypical EPEC strains also belong 
to the typical EPEC lineages [21]. Thus, it has been hypothesized that at least some 
atypical EPEC may have originated from typical EPEC strains that lost pEAF in the 
host or in the environment [21].
3. Epidemiology of EPEC
3.1 Incidence
The prevalence of EPEC infection varies between epidemiological studies based 
on differences in study populations, age, distributions, and methods used for 
detection and diagnosis [22]. Also, geographic region and socioeconomic class may 
contribute to the epidemiology of EPEC-induced diarrheal disease [23]. Adults and 
older children with typical EPEC infections are rarely reported; this has been attrib-
uted to the loss of specific receptors with age or development of immunity [24].
For the two last decades, studies conducted worldwide have shown the association 
of typical EPEC serotypes with diarrhea in children <1 year of age, mainly in poor 
children of urban centers [24]. This association was particularly strong in infants less 
than 6 months of age. Between 1977 and 1982, epidemiologic studies in Brazil, Chile, 
Mexico, and South Africa have shown that 30–40% of infantile diarrhea was caused 
by typical EPEC serotypes [22]. However, recent studies in these countries have not 
identified a significant association between typical EPEC and infantile diarrhea. At 
this time, a change in the epidemiology of EPEC occurred in both developing and 
developed countries. The proportion of atypical EPEC strains has increased and out-
numbered typical EPEC strains, and atypical EPEC strains have also been associated 
with childhood diarrhea in both developing and developed countries [19, 22, 25].  
In Brazil, 92% of EPEC isolates collected from children between 2001 and 2002 were 
atypical [26], compared to 38% in a 1998–1999 study [27–29]. However, other studies 
still report typical being more prevalent than atypical EPEC as a cause of diarrhea 
[30]. Recently, a prospective, population-based case-control study involving seven 
sites in Africa and Asia showed that typical EPEC was significantly associated with 
moderate to severe diarrhea in children under 2 years of age in Kenya, whereas atypi-
cal EPEC was not associated with this type of diarrhea [31].
3.2 Transmission and reservoirs
Typical EPEC transmission follows a fecal-oral process through contaminated 
surfaces, weaning fluids, and human carriers [32]. EPEC outbreaks among adults, 
although rare, seem to occur through ingestion of contaminated food and water; 
however, no specific environmental reservoir has been identified [24]. EPEC 
outbreaks have been reported to show a seasonal distribution with peaks during the 
warm months [33]. Humans are the only known reservoir for typical EPEC, with 
symptomatic and asymptomatic children and asymptomatic adults being the most 
likely source [24].
In contrast to the tEPEC, many aEPEC strains have been found in diarrheic as 
well as in healthy animals and from the environment. Interestingly, animal aEPEC 
serogroups associated with human diarrhea have been identified (e.g., O26, O103, 
O119, O128, O142, and O157); however, so far a direct transmission from animals to 
humans has not been confirmed. In addition, foods including raw meats, pasteur-
ized milk, meat samples, vegetables, and water have been also implicated as vehicles 
of aEPEC to human infections (reviewed in [34, 35]).
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4. EPEC virulence factors and genetics
4.1 Localized adherence
Typical EPEC strains adhere to HeLa, HEp-2, and other cell lines and to organ 
cultures in vitro in a distinctive pattern of three-dimensional microcolonies so-called 
localized adherence (LA) pattern within 3 h of infection (Figure 1A) [8, 24].  
A similar adherence pattern has been seen in tissue biopsies of EPEC-infected 
humans [37]. The LA phenotype is mediated by a type IV fimbriae bundle-forming 
pilus (BFP) associated with the EAF plasmid, which mediates bacterium-to-bacte-
rium adherence, resulting in formation of compact microcolonies [38].
Atypical EPEC strains may display a variant LA pattern designated LA-like 
(LAL) pattern, which is characterized by the presence of loose compact microcolo-
nies or clusters of bacteria in few cells observed in tests using prolonged incubation 
periods (6 h) (Figure 1B) [39, 40]. Interestingly, the LAL pattern is determined in 
prolonged assays (6 h) of bacteria-cell interaction [39]. LAL is the most common 
pattern seen among EPEC strains; however, some strains display alternate adherence 
phenotypes such as diffuse adherence (DA) and aggregative adherence (AA) [19].
4.2 Attaching and effacing (A/E) lesion
The hallmark of EPEC infection is the ability of the organism to attach inti-
mately to epithelial cells and efface microvilli (Figure 1C). This effect was first 
described by Staley et al. [41], although the term attaching and effacing (A/E) 
Figure 1. 
EPEC adhesion to epithelial cells: (A) localized adherence pattern (LA) of typical EPEC on HeLa cells; (B) 
localized adherence-like (LAL) pattern of atypical EPEC on HeLa cells; (C) attaching and effacing (A/E) of 
enterocytes by EPEC; and (D) small bowel biopsy of infant infected with typical EPEC O111ab:H2 [36].
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was coined by Moon et al. [13]. The A/E characteristic can be observed by electron 
microscopic examination of cultured epithelial cells exposed to EPEC or of intesti-
nal biopsies from infants or animals infected with EPEC [24].
4.3 Invasiveness
Intracellular typical EPEC have been observed both in tissue culture and in small 
intestinal biopsies from an EPEC-infected infant (Figure 1D) [36]. Fletcher et al. [42] 
and Scaletsky et al. [43] have reported that EPEC O111:NM strains contain plasmid 
sequences that confer invasiveness upon E. coli K12 strains. However, despite their 
invasive potential in vitro, most EPEC are considered as noninvasive pathogens [44].
4.4 Biofilm formation
Typical EPEC have the ability to form biofilms on abiotic surfaces under static 
conditions, or on a flow through continuous culture system, and a model of EPEC 
biofilm formation has been proposed [45]. Biofilm formation requires adhesive struc-
tures as type 1 pili, antigen 43, BFP, and the EspA filament (see below) as participants 
in bacterial aggregation during biofilm formation on abiotic surfaces [45]. Atypical 
EPEC strains have also been shown to adhere to abiotic surfaces (polystyrene and 
glass) [46, 47]. The non-fimbrial adhesin curli and the T1P were shown to mediate 
binding to these surfaces in some atypical EPEC at different temperatures [48, 49].
4.5 The EAF plasmid
Typical EPEC strains possess a large virulence plasmid called the EPEC adherence 
factor (EAF) plasmid [9], which varies in sequence among different EPEC strains 
but is somewhat conserved [12]. The EAF plasmid pMAR2 is found among strains of the 
EPEC1 lineage, whereas pB171 is more common among EPEC2 strains [50, 51]. Two sets 
of genes located on the EAF plasmid are important for pathogenicity: the bfp gene 
cluster encoding BFP [38] and the per locus encoding a transcriptional activator called 
plasmid-encoded regulator (Per) [51]. Both BFP and PerA have been shown to contrib-
ute to virulence in human volunteers [52]. Between pMAR2 and pB171, the bfp and per 
loci share 99% sequence similarity [50]. Studies of comparison genomics of the EAF 
plasmids from varied EPEC phylogenomic lineages demonstrated significant plasmid 
diversity among isolates within the same phylogenomic lineage [53].
4.6 Bundle-forming pilus (BFP)
Typical EPEC strains produce a type IV pilus, the bundle-forming pili (BFP), 
which interconnects bacteria within microcolonies, promoting their stabilization and 
producing the LA phenotype [38]. The BFP is encoded by an operon of 14 genes con-
tained on the EAF plasmid, with bfpA encoding the major structural subunit (bund-
lin) [54]. These 14 bfp genes are highly conserved among EPEC1 and EPEC2 strains. 
Some O128:H2 and O119:H2 EPEC strains that contain part of the bfpA gene have the 
rest of the bfp gene cluster deleted and replaced with an IS66 element [55, 56].
4.7 The locus of enterocyte effacement (LEE) and the type III secretion  
system (TTSS)
The locus of enterocyte effacement (LEE) is a 35.6-kb pathogenicity island of 
EPEC containing genes necessary for the formation of the A/E lesion [57]. The EPEC 
LEE contains at least 41 open reading frames that are organized into five operons 
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(LEE1 to LEE5) [58–60]. LEE1, LEE2, and LEE3 encode a type III protein secretion 
system (T3SS) and Ler (LEE-encoded regulator) regulators, such as GrlA (global 
regulator of LEE activator, formerly called Orf11) and GrlR (Grl repressor, formerly 
called Orf10) [61]. LEE4 encodes the EPEC-secreted proteins EspA, EspB, and EspD 
via the type III system. LEE5 encodes intimin and its translocated receptor, Tir [62]. 
Besides Tir, the EPEC genome contains other six LEE-encoded effector proteins 
translocated into the cell (Map, EspF, EspG, EspZ, EspH, and EspB), which interfere 
with different aspects of the cell physiology ([58, 59]; reviewed in [44]) [63].
In addition to the LEE effectors, various non-LEE (Nle)-encoded effector genes (cif, 
espI/nleA, nleB, nleC, nleD, nleE, and nleH) [59, 63] were described, which are located 
outside the LEE region of EPEC, in at least six chromosomal PAIs, or in prophage 
elements (reviewed in [64] and [65]). Although they are not required for AE lesion 
formation, it is understood that they contribute to increased bacterial virulence [66].
The LEE region of some atypical EPEC strains display a genetic organization 
similar to that found in the typical EPEC prototype E2348/69 strain [66]. Although 
the T3SS-encoding genes are considerably conserved [66, 67], the effector protein-
encoding genes display important differences, and remarkable differences can be 
detected at the 5′ and 3′ flanking regions of atypical EPEC, suggesting the occur-
rence of different evolution events [68].
The expression of LEE genes is controlled by Per, which is encoded on the EAF 
plasmid present in typical EPEC strains. Per activates Ler, which in turn activates 
the LEE2, LEE3, LEE4, and LEE5 operons, and the genes espF, espG, and map [58, 59]. 
The Ler protein is a histone-like nucleoid-structuring protein (H-NS) that responds 
to an environmental stimulus (temperature). Ler also controls genes located outside 
the LEE, such as espC and nleA [60]. Additional regulatory system has been shown 
to control expression of the LEE [69]. The AI-2 (autoinducer-2) quorum-sensing 
system regulates LEE1 operon, which increases expression of the LEE3 and LEE4 
operons via the ler gene product. Two novel LEE-encoded regulators that have roles 
in ler expression were reported, GrlA (global regulator of LEE activator) and GrlR 
(Grl repressor) [61]. GrlR and GrlA are positive and negative regulators, respec-
tively, required for the expression of several LEE-encoded genes [61]. Other LEE 
regulators include the integration host factor (IHF); Bip, a tyrosine-phosphorylated 
GTPase; Fis (factor for inversion stimulation); and GadX, which is a member of the 
AraC transcription factor family [58].
4.8 Intimin and Tir
Intimin is a 94-KDa outer membrane adhesin encoded by the eae gene and 
required for intimate adherence of EPEC to epithelial cells at the sites of A/E lesions 
[24]. N-Terminal portions are highly conserved, whereas C-terminus portions are 
highly variable [70]. C-Terminal intimin differences have been used as a basis for clas-
sification into several distinct subtypes (represented by the Greek letters to α (alpha) 
through ζ (zeta) [71, 72]); human EPEC1 strains express subtype α, while EPEC2 
strains express subtype β. The N-terminus portion binds intimin in the bacterial 
outer membrane, whereas the C-terminus portion binds intimin to Tir. The binding 
of intimin to Tir leads to intimate adherence of the bacterium to the epithelium and 
pedestal formation beneath adherent bacteria. In addition, Tir inhibits NF-қB activity 
by targeting tumor necrosis factor alpha (TNF-α) receptor-associated factors [73].
4.9 Other potential adhesins
In addition to BFP, two other EPEC surface structures, rodlike fimbriae and 
fibrillae, have been characterized and have been suggested to be involved in the 
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interaction of EPEC with host cells [74, 75]. Additionally, EPEC strains encode 
a large surface protein, lymphocyte inhibitory factor (LifA), that contributes to 
epithelial cell adherence in vitro [76, 77] and is required for intestinal coloniza-
tion of mice by the related A/E pathogen C. rodentium [78]. The lifA gene is more 
commonly found among typical rather than atypical EPEC strains [79]; however, 
atypical EPEC strains harboring lifA have a significant association with diarrhea 
in children under 5 years of age [80]. A novel gene cluster, designated the locus for 
diffuse adherence (lda), was found in an atypical EPEC O26 strain that is respon-
sible for mediating DA adherence; its expression is induced by bile salts [81]. The 
E. coli common pilus (ECP) has also been shown to act as an accessory adherence 
factor in EPEC, playing a role during cell adherence and/or in bacterium-bacterium 
interactions [82].
4.10 Flagella
Flagella has been suggested to be involved in EPEC adherence to epithelial cells 
[83]. EPEC mutants with transposon insertion in the flagellar gene fliC were defi-
cient in localized adherence, and anti-flagellum antibodies were effective in block-
ing the adherence of several EPEC serotypes [83]. However, a subsequent study has 
not confirmed a role of flagella in EPEC adherence [84].
5. EspC
EspC is a high-molecular-weight secreted protein of EPEC that induces cyto-
pathic effects on epithelial cells, including cytoskeletal damage [24, 85]. EspC is a 
member of the serine protease autotransporters of the Enterobacteriaceae (SPATE) 
family of autotransporter proteins that encodes its own transport mechanism. 
Moreover, espC has been shown to interact with and degrade hemoglobin [86] and 
to hydrolyze other proteins such as pepsin, factor V, and spectrin [87]. In addition, 
EspC confers enhanced lysozyme resistance to EPEC [87] and serves as a substra-
tum for adherence and biofilm formation as well as to protect bacteria from antimi-
crobial compounds [88]. EspC is encoded in a 15-kb chromosomal island specific to 
EPEC1 strains [24].
6. Other toxins
Scott and Kaper [89] reported a cytolethal distending toxin (CDT) in an EPEC 
strain that induces chromatin disruption, which leads to G2/M-phase growth 
arrest of the target cell and ultimately cell death [90]. A study has suggested that 
most EPEC strains from diarrhea harbor the CDT gene [91]. Another toxin is the 
enteroaggregative E. coli heat-stable enterotoxin 1 (EAST1) also present in EPEC 
strains [92]. The use of an EAST1 DNA probe suggests that this toxin is expressed 
by a number of clinical EPEC isolates [18, 93]. The role of CDT and EAST1 in EPEC 
pathogenesis remains to be elucidated.
7. Model of EPEC pathogenesis
A three-stage model of EPEC pathogenesis was first described in the early 1990s 
[94], Clarke et al. [95], including localized adherence to the host cell, signal trans-
duction, and intimate attachment with pedestal formation (Figure 2).  
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In the first stage, an attachment of typical EPEC to the surface of the host intestinal 
epithelium is mediated by the bundle-forming pili (BFP). The filament EspA also 
promotes attachment, albeit in a less efficient manner, and could mediate adherence 
of atypical EPEC strains. In the second stage, Tir and effector proteins (EspB, EspD, 
EspF, EspG, and Map), translocated into the host cells via type III system apparatus, 
activate cell-signaling pathways, causing alterations in the host cell cytoskeleton 
and resulting in actin accumulation and loss of microvilli [58]. In the third stage, 
bacteria intimately adhered to host cell by intimin-Tir interactions amplifies the 
accumulation of filaments of actin and other cytoskeletal proteins that result in 
pedestal-like structures [62, 96, 97]. Finally, the translocated effectors disrupt host 
cell processes, causing loss of tight-junction integrity and mitochondrial function 
and leading to both electrolyte loss and eventual cell death.
8. Diagnosis
Traditionally, the identification of EPEC was based on the O:H serotyping, but 
serotype designation is no longer precise. The identification of EPEC was based on 
the characteristic of EPEC’s attachment to epithelial cells and may include pheno-
typic or genotypic tests. The HeLa adherence assay distinguishes EPEC from other 
E. coli by their ability to adhere in a localized pattern (LA) on the surface of cells 
[8]. The fluorescent actin-staining (FAS) assay, originally described by Knutton 
et al. [98], leads to the identification of the A/E lesion, by detecting actin con-
densation under EPEC adhesion pedestals. DNA probes and PCR targeting genes 
responsible for these characteristics were developed. A 1-kb EAF fragment probe 
was initially developed as a diagnostic DNA probe (the EAF probe) and subse-
quently refined as an oligonucleotide probe as well as PCR primers [10, 11, 99].  
The identification of bfpA, the structural gene encoding BFP, led to the develop-
ment of more specific and sensitive probe or PCR tests to detect typical EPEC 
strains [74, 75, 100]. However, some PCR primers may fail to identify all typical 
EPEC strains since multiple alleles of bfpA have been identified [101]. The eae 
sequences by DNA probes and PCR primers have been used to detect the presence 
of LEE encoding A/E lesion [24].
Figure 2. 
Four-stage model of EPEC pathogenesis. Reprinted from Clarke et al. [95].
9Enteropathogenic Escherichia coli
DOI: http://dx.doi.org/10.5772/intechopen.82861
9. Clinical features of EPEC infection
9.1 Symptoms
The most common symptoms reported in EPEC infection are watery diarrhea, 
dehydration, vomiting, food intolerance, and low-grade fever [24, 97]. In addition, 
EPEC infection may lead to severe malabsorption of nutrients resulting in nutri-
tional aggravation and persistence of diarrhea [102]. Edema, neutrophil infiltrate, 
and reduced enzymatic activity in the intestinal mucosa have been also found in 
EPEC infection [103]. EPEC diarrhea often lasts 1–2 weeks but can become persis-
tent, lasting more than 2 weeks, and may result in severe infection [24, 25, 32, 102]. 
In a recent case-control study, EPEC infection was associated with a 2.8-fold elevated 
risk of death among infants in Kenya [24, 31, 97].
9.2 Treatment
Treatment of EPEC diarrhea includes oral rehydration therapy to prevent 
dehydration by correcting fluid and electrolyte losses. Oral rehydration may be suf-
ficient for cases of self-limited acute diarrhea, but persistent cases of diarrhea may 
include parenteral rehydration, and more severe cases may require total parental 
nutrition and use of antimicrobials [102]. Multidrug resistance has been reported 
in EPEC strains from diverse parts of the world [27–29, 44, 104, 105]. Alternative 
therapies, employing the use of bismuth subsalicylate, specific bovine anti-EPEC 
milk immunoglobulins, and also zinc, have been proven useful for treatment and 
prevention of EPEC diarrhea [106].
9.3 Vaccines
There are no currently available vaccines to prevent EPEC infection. However, a 
recent study has used bacterial ghosts devoid of cytoplasmic contents but express-
ing all EPEC surface components in vaccination challenge experiments with mice, 
and the results showed 84–90% protection in control mice [107]. Interestingly, 
protective effect of breast-feeding was shown to provide excellent protection 
against EPEC infection. Several investigators have shown that breast milk provides 
protection against EPEC O antigens and outer membrane proteins [108, 109]. 
Furthermore, IgA antibodies against BFP, intimin, EspA, and EspB proteins were 
identified in maternal colostrum and serum samples [110–118].
10. Conclusion
Much progress has been made in the last 20 years toward understanding the 
pathogenesis of EPEC. It has been shown that typical EPEC are still important 
pathogens associated with severe outbreaks of infant diarrhea, and atypical EPEC 
are emerging pathogens associated with sporadic outbreaks at all ages worldwide.
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